-
Pharmaceuticals
- Digital Health
- Radiology
- Speciality Medicine & General Medicine
- Clinical trials
-
Collaboration
- Patient group donations
- Payments to Patients, Public and Media
- Collaborative working
- Completed collaborative working
- Transfers of value to Healthcare Professionals and HealthcareOrganisations
- How Bayer works together with Healthcare Professionals
- What the EFPIA Disclosure code is about
- Data Disclosure
- Donations and Grants
- Consumer Health
- CropScience
Payments to Patients, Members of the Public & Media
Patient Group Donations 2022
Bayer is committed to communicating appropriately about new and innovative therapies for severe and chronic diseases. Patients speaking about their experiences with their disease, members of the public lending their expertise and media amplifying new developments in medicine, help to generate awareness about diseases and effective interventions.
The most recent patients, members of the public and media to which Bayer has provided financial support are listed below.
Correct at 19 June 2023
Special Links